Kenya has been picked among nine countries for the trials of the new injectable HIV prevention drug that has been rolled out ...

Kenya has been selected as one of the 9 early adopter countries for the rollout of Lenacapavir (LEN), a long-acting ...

Healthcare workers at risk as Kenya faces funding cuts threatening HIV programs. Kenya requires Sh 5.24 billion for the 2024/2025 fiscal year and Sh 13.5 billion for 2025/2026 to maintain its ...

Kenya is among the countries supported by GF, but how soon it receives the new drug will depend on, among other factors, how fast the Pharmacy and Poisons Board approves its use locally.

Standard Group Plc HQ Office, The Standard Group Center,Mombasa Road. P.O Box 30080-00100,Nairobi, Kenya. Telephone number: 0203222111, 0719012111 ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of the EXPrESSIVE Phase 3 clinical trials, evaluating the safety and efficacy of MK-8527, an ...

Integrating people-centered HIV care with primary health care is essential to improving access, equity and health outcomes, but doing so successfully requires coordinated policies, digital ...

HIV incidence rates remain higher than the level of epidemic control in many African countries. Despite the availability of cost-free, highly-effective HIV prevention interventions, such as ...